3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
25
Carcinoma, Hepatocellular
22
Small Cell Lung Carcinoma
17
Lung Neoplasms
14
Neoplasms
13
Breast Neoplasms
9
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Melanoma
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Neoplasm Metastasis
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
pembrolizumab
3
Radiotherapy
3
Radiation
3
Biopsy
3
pazopanib
2
palbociclib
2
abemaciclib
2
Immunoglobulin G
2
Ifosfamide
2
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
mirdametinib
1
liposomal doxorubicin
1
eribulin
1
durvalumab
1
cemiplimab
1
X-Rays
1
Vincristine
1
Temozolomide
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
atezolizumab
×
90 days
×
Clear all
No trials found.